Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04219371 · ClinicalTrials.gov registry record
Reference Range Study for the Quantra QStat System
A clinical trial of Coagulation Disorder, sponsored by HemoSonics.
- Completed
- Registry status
- 140
- Enrollment target
- 3
- Study locations
NCT04219371: Completed study of Coagulation Disorder, sponsored by HemoSonics.
NCT04219371 is a study of Coagulation Disorder that has completed, run by HemoSonics. The registered enrollment target is 140 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04219371, a study of Coagulation Disorder, has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective is to determine the reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge.
Primary Outcome
Reference range intervals determined in this study will serve as the reference range for CT on the QStat Cartridge when it is commercially available.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quantra System
Study Locations (3)
Georgia
- WR-Mount Vernon Clinical Research, LLC - Sandy Springs
North Carolina
- M3 Wake Research - Raleigh
Tennessee
- WR-ClinSearch, LLC - Chattanooga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-01-07 |
| Est. Completion | 2020-06-30 |
What the finished NCT04219371 record still lists
NCT04219371 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Coagulation Disorder appearing as the primary indexed condition, and to 1 intervention - of which Quantra System is the first listed.
NCT04219371 reports a single indexed study location in Georgia, North Carolina, Tennessee.
Frequently Asked Questions
What is clinical trial NCT04219371 about?
NCT04219371 is a clinical study titled "Reference Range Study for the Quantra QStat System". The objective is to determine the reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge.
What is the current status of trial NCT04219371?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2020-01-07. Estimated completion is 2020-06-30.
What conditions does trial NCT04219371 study?
This clinical trial studies the following conditions: Coagulation Disorder.
What interventions are being tested in trial NCT04219371?
The interventions under investigation include: Quantra System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04219371?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04219371 being conducted?
This trial has 3 study locations across Georgia, North Carolina, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coagulation Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI